AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 136 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 5.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764 | -50.3% | 16,620 | -37.9% | 0.32% | -47.5% |
| Q2 2023 | $1,538 | +58.6% | 26,758 | +3.4% | 0.62% | +51.1% |
| Q1 2023 | $970 | -99.9% | 25,877 | -6.2% | 0.41% | +12.1% |
| Q3 2022 | $775,000 | -28.1% | 27,577 | -4.4% | 0.36% | -16.7% |
| Q2 2022 | $1,078,000 | -39.7% | 28,837 | -42.1% | 0.44% | -33.2% |
| Q1 2022 | $1,788,000 | +160.6% | 49,814 | +36.1% | 0.65% | +110.0% |
| Q3 2020 | $686,000 | – | 36,590 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |